Gene expression: Page 2

Castle Biosciences reports study validation for melanoma gene expression test
By Maryam Payne
The study findings support results from a recently published study which showed that patients who received routine imaging guided by high-risk 31-GEP test scores had earlier diagnoses of recurrence, which in turn led to better outcomes for patients.
July 6, 2023
Pathology Slide Melanoma Social
Biocartis, HiloProbe collaborating to commercialize, distribute colorectal cancer gene-expression test
By LabPulse.com staff writers
The test, ColoNode, is CE-marked and will be distributed first as a manual kit by Biocartis to expert laboratories in selected European countries.
May 9, 2023
Dna Genome Gene Targeted Social
Oncocyte to lay off 20% of workforce in cost restructuring
By Leo O'Connor
The CEO said the layoff is part of a plan to bring its cost structure in line with its kitted product strategy and to optimize operational efficiency.
April 13, 2023
Dna Genome Gene Targeted Social
Oncocyte prices $13.86M public offering to support test development, commercialization
By LabPulse.com staff writers
Oncocyte intends to use the net proceeds from the offering primarily to promote the development and commercialization of VitaGraft, DetermaIO, and DetermaCNI precision diagnostic tests.
April 3, 2023
Lung Cancer2 Social
Study supports genetic testing for people with cerebral palsy
By Elissa Wolfson
A meta-analysis of recent cerebral palsy research suggests that genetic testing could be offered as the standard procedure for people with the disorder.
March 7, 2023
Dna Sequencing Data Analysis Social
Immune-response test in study detects COVID-19 with near-perfect accuracy
By Elissa Wolfson
A test that monitors the body’s molecular response to the SARS‑CoV‑2 virus can diagnose even asymptomatic patients with near-perfect accuracy, the researchers said.
March 1, 2023
Coronavirus Covid Blue Social
BlueStar Genomics announces rebranding as ClearNote Health, commercialization of pancreatic cancer test
By LabPulse.com staff writers
The DNA-based blood test is already available in the U.S. through the ClearNote Health physician experience program.
December 22, 2022
Pancreas New Social
Molecular signature in study sheds light on adjuvant radiation therapy after breast-conserving surgery
By LabPulse.com staff writers
Low scores on an investigational gene molecular signature suggest similar rates of local recurrence whether or not patients received adjuvant radiation therapy after breast-conserving surgery.
December 9, 2022
Radiotherapy Breast Cancer Social
Exact Sciences shares validation data for breast cancer radiation signature at SABCS
By LabPulse.com staff writers
The data presented as part of SABCS’s press program were from a meta-analysis of three independent, randomized clinical trials that identified which early-stage breast cancer patients benefited from radiotherapy after breast-conserving surgery.
December 12, 2022
Breast Mammo Social
BillionToOne announces clinical data on NIPT for recessive conditions
By LabPulse.com staff writers
The firm's Unity Screen is designed to assess fetal risk of recessive conditions such as cystic fibrosis, sickle cell disease, the thalassemias, and spinal muscular atrophy.
December 6, 2022
Eye Dna Genes Social
Agendia to present abstracts on gene expression profiling tests at 2022 San Antonio Breast Cancer Symposium
By LabPulse.com staff writers
Six studies focus on the impact of Agendia's MammaPrint and BluePrint tests and their ability to unveil the underlying biology of a breast cancer patient’s tumor to inform personalized treatment decisions.
December 6, 2022
Breast Cancer3 Social
At SABCS, University of Rochester professor presents clinical trial results for Biotheranostics Breast Cancer Index
By LabPulse.com staff writers
The Breast Cancer Index test is the first biomarker to be evaluated in a cohort from the Suppression of Ovarian Function Trial (SOFT), Hologic noted.
December 7, 2022
Breast Cancer 3 D Social
Previous Page
Page 2 of 4
Next Page